Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Matthew Zeglinski is active.

Publication


Featured researches published by Matthew Zeglinski.


Chest | 2012

Obstructive Sleep Apnea : Effects of Continuous Positive Airway Pressure on Cardiac Remodeling as Assessed by Cardiac Biomarkers, Echocardiography, and Cardiac MRI

Jane Colish; Jonathan R. Walker; Nader Elmayergi; Saleh Almutairi; Fawaz Alharbi; Matthew Lytwyn; Andrew Francis; Sheena Bohonis; Matthew Zeglinski; Iain D.C. Kirkpatrick; Sat Sharma; Davinder S. Jassal

BACKGROUNDnObstructive sleep apnea (OSA) is associated with an increased risk of cardiovascular morbidity and mortality. Although previous echocardiographic studies have demonstrated short-term improvement in cardiovascular remodeling in patients with OSA receiving continuous positive airway pressure (CPAP) therapy, a long-term study incorporating cardiac biomarkers, echocardiography, and cardiac MRI (CMR) has not been performed to date.nnnMETHODSnA prospective study of 47 patients with OSA was performed between 2007 and 2010. Cardiac biomarkers, including C-reactive protein (CRP), N-terminal pro-B-type natriuretic peptide (NT-proBNP), and troponin T (TnT), were measured at baseline and serially over 1 year. All patients underwent baseline and serial transthoracic echocardiography (TTE) and CMR to assess cardiac remodeling.nnnRESULTSnFollowing 12 months of CPAP therapy, levels of CRP, NT-proBNP, and TnT did not change significantly from normal baseline values. As early as 3 months after initiation of CPAP, TTE revealed an improvement in right ventricular end-diastolic diameter, left atrial volume index, right atrial volume index, and degree of pulmonary hypertension, which continued to improve over 1 year of follow-up. Finally, left ventricular mass, as determined by CMR, decreased from 159 ± 12 g/m(2) to 141 ± 8 g/m(2) as early as 6 months into CPAP therapy and continued to improve until completion of the study at 1 year.nnnCONCLUSIONnBoth systolic and diastolic abnormalities in patients with OSA can be reversed as early as 3 months into CPAP therapy, with progressive improvement in cardiovascular remodeling over 1 year as assessed by both TTE and CMR.


Echocardiography-a Journal of Cardiovascular Ultrasound and Allied Techniques | 2012

Multimodality Imaging of Aortic Dimensions: Comparison of Transthoracic Echocardiography with Multidetector Row Computed Tomography

James F. Tsang; Matthew Lytwyn; Ashraf Farag; Matthew Zeglinski; Kerrett Wallace; Megan daSilva; Sheena Bohonis; Jonathan R. Walker; James W. Tam; Jacek Strzelczyk; Davinder S. Jassal

Background: With recent advances in multimodality cardiac imaging, a number of methods exist for the noninvasive assessment of aortic disease. Although multidetector row computed tomography (MDCT) remains the gold standard for aortic measurements, there are a number of limitations including radiation and contrast‐induced nephropathy. Transthoracic echocardiography (TTE) is an alternative to MDCT for providing accurate anatomic assessment of aortic root and ascending aorta dimensions. Objectives and Methods: To determine the accuracy of two‐dimensional (2D) TTE for determining aortic measurements in comparison to MDCT, a retrospective study of individuals with varying aortic root and ascending aorta dimensions was performed. Results: There were 116 patients (77 males, mean age 49 ± 12 years) in total. The maximum aortic diameters by 2D TTE were 26.1 ± 4.3 mm (annulus), 32.4 ± 5.6 mm (sinuses), 30.1 ± 5.9 mm (sinotubular [ST] junction), and 33.4 ± 7.3 mm (ascending aorta). The maximum aortic diameters by MDCT were 30.1 ± 4.1 mm (annulus), 35.8 ± 5.8 mm (sinuses), 33.2 ± 5.9 mm (ST junction), and 37.4 ± 7.6 mm (ascending aorta). There was good to excellent correlation between 2D TTE and MDCT at all four levels of the aorta (annulus: r = 0.84; sinuses: r = 0.93; ST junction: r = 0.93; ascending aorta: r = 0.88). There was a consistent underestimation of aortic measurements obtained by 2D TTE when compared to MDCT. Conclusion: 2DTTE is a feasible, accurate, and reproducible method for the noninvasive assessment of thoracic aortic diameters as compared to MDCT. (Echocardiography 2012;29:735‐741)


Cardiovascular Ultrasound | 2011

Evaluating the effectiveness of rosuvastatin in preventing the progression of diastolic dysfunction in aortic stenosis: A substudy of the aortic stenosis progression observation measuring effects of rosuvastatin (ASTRONOMER) study

Davinder S. Jassal; Kapil M. Bhagirath; Erin Karlstedt; Matthew Zeglinski; Jean G. Dumesnil; Koon K. Teo; James W. Tam; Kwan L. Chan

BackgroundTissue Doppler imaging (TDI) is a noninvasive echocardiographic method for the diagnosis of diastolic dysfunction in patients with varying degrees of aortic stenosis (AS). Little is known however, on the utility of TDI in the serial assessment of diastolic abnormalities in AS.ObjectiveThe aim of the current proposal was to examine whether treatment with rosuvastatin was successful in improving diastolic abnormalities in patients enrolled in the Aortic Stenosis Progression Observation Measuring Effects of Rosuvastatin (ASTRONOMER) study.MethodsConventional Doppler indices including peak early (E) and late (A) transmitral velocities, and E/A ratio were measured from spectral Doppler. Tissue Doppler measurements including early (E) and late (A) velocities of the lateral annulus were determined, and E/E was calculated.ResultsThe study population included 168 patients (56 ± 13 years), whose AS severity was categorized based on peak velocity at baseline (Group I: 2.5-3.0 m/s; Group II: 3.1-3.5 m/s; Group III: 3.6-4.0 m/s). Baseline and follow-up hemodynamics, LV dimensions and diastolic functional parameters were evaluated in all three groups. There was increased diastolic dysfunction from baseline to follow-up in each of the placebo and rosuvastatin groups. In patients with increasing severity of AS in Groups I and II, the lateral E was lower and the E/E (as an estimate of increased left ventricular end-diastolic pressure) was higher at baseline (p < 0.05). However, treatment with rosuvastatin did not affect the progression of diastolic dysfunction from baseline to 3.5 year follow-up between patients in any of the three predefined groups.ConclusionIn patients with mild to moderate asymptomatic AS, rosuvastatin did not attenuate the progression of diastolic dysfunction.


Journal of Medical Case Reports | 2011

Diagnosis of pericardial cysts using diffusion weighted magnetic resonance imaging: A case series

Asam Raja; Jonathon R. Walker; Maneesh Sud; Joe Du; Matthew Zeglinski; Andrew Czarnecki; Negareh Mousavi; Davinder S. Jassal; Iain D.C. Kirkpatrick

IntroductionCongenital pericardial cysts are benign lesions that arise from the pericardium during embryonic development. The diagnosis is based on typical imaging features, but atypical locations and signal magnetic resonance imaging sequences make it difficult to exclude other lesions. Diffusion-weighted magnetic resonance imaging is a novel method that can be used to differentiate tissues based on their restriction to proton diffusion. Its use in differentiating pericardial cysts from other pericardial lesions has not yet been described.Case presentationWe present three cases (a 51-year-old Caucasian woman, a 66-year-old Caucasian woman and a 77-year-old Caucasian woman) with pericardial cysts evaluated with diffusion-weighted imaging using cardiac magnetic resonance imaging. Each lesion demonstrated a high apparent diffusion coefficient similar to that of free water.ConclusionThis case series is the first attempt to investigate the utility of diffusion-weighted magnetic resonance imaging in the assessment of pericardial cysts. Diffusion-weighted imaging may be a useful noninvasive diagnostic tool for pericardial cysts when conventional imaging findings are inconclusive.


Canadian Journal of Physiology and Pharmacology | 2013

The effects of fish oil consumption on cardiovascular remodeling in ApoE deficient mice

Kelby Cleverley; Xiaozhou Du; Sheena Premecz; Khuong Le; Matthew Zeglinski; Tiffany Nicholson; Chun Y. Goh; Yan Lu; Hope D. Anderson; Mohammed H. Moghadasian; Davinder S. Jassal

Owing to their spontaneous development of atherosclerosis, apolipoprotein E knockout mice (ApoE(KO)) are one of the best studied animal models for this disease. Little is known about the utility of various omega-3 fatty acid regimens, in particular fish oils, in preventing cardiac disease in ApoE(KO) mice. The purpose of this study was to determine the cardiovascular effects of omega-3 fatty acid supplementation with either safflower oil (control), fish oil, flaxseed oil, or designed oil in ApoE(KO) mice fed a high-fat diet for a total of 16 weeks. In-vivo cardiac function was assessed weekly using murine echocardiography. Blood pressure, plasma lipid levels, and brain natriuretic peptide (BNP) were serially measured. The results show that ApoE(KO) mice fed fish oil demonstrated an increase in left ventricular wall thickness as a result of increased afterload. Despite chronic treatment with fish oil over 16 weeks, blood pressure increased in ApoE(KO) mice by 20% compared with the baseline. Both echocardiographic evidence of left ventricular hypertrophy and biochemical increase in BNP levels confirmed diastolic dysfunction in ApoE(KO) mice fed fish oil. This suggests that high-fat diet supplemented with fish oil may lead to adverse cardiovascular effects in ApoE deficient mice.


Cardiovascular Ultrasound | 2010

An unusual case of left ventricular aneurysm in duchenne muscular dystrophy

Xiaozhou Du; Matthew Zeglinski; Nasir Shaikh; Davinder S. Jassal

Duchenne muscular dystrophy (DMD) leads to structural heart disease, including dilated cardiomyopathy, in 90% of patients >18 years of age. Despite the ubiquity of cardiomyopathy associated with DMD, ventricular aneurysms in these patients have rarely been reported. We present a case of a basal inferoposterior aneurysm of the left ventricle in a 23-year-old male patient with DMD.


Experimental & Clinical Cardiology | 2011

Trastuzumab-induced cardiac dysfunction: A 'dual-hit'

Matthew Zeglinski; Ana Ludke; Davinder S. Jassal; Pawan K. Singal


Archive | 2015

myofibroblasts by a Smad-independent mechanism

Matthew Zeglinski; Patricia Roche; Mark Hnatowich; Davinder S. Jassal; Michael P. Czubryt; Ian M. C. Dixon


Archive | 2014

Basic Research Congenital Absence of Nitric Oxide Synthase 3 Potentiates Cardiac Dysfunction and Reduces Survival in Doxorubicin- and Trastuzumab-Mediated Cardiomyopathy

Matthew Zeglinski; Sheena Premecz; Rakesh Chaudhary; Anita K. Sharma; James A. Thliveris; Amir Ravandi; Pawan K. Singal; Davinder S. Jassal


Circulation | 2011

Abstract 8681: The Cardioprotective Role of Renin-Angiotensin System Antagonism in the Prevention of Doxorubicin and Trastuzumab Mediated Cardiac Dysfunction

Navdeep Bhullar; Marian Kotrec; Matthew Zeglinski; Mehrdad Golian; Megan daSilva; Matthew Lytwyn; Sheena Bohonis; Tielan Fang; Sacha Oomah; Roman Nepomuceno; Xiaozhou Du; Erin Karlstedt; Anita K. Sharma; Philip J. Garber; Pawan K. Singal; Davinder S. Jassal

Collaboration


Dive into the Matthew Zeglinski's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Sheena Bohonis

St. Boniface General Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Megan daSilva

St. Boniface General Hospital

View shared research outputs
Top Co-Authors

Avatar

Xiaozhou Du

St. Boniface General Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge